PGI19 COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH PEGINTERFERON-ALFA-2A VERSUS PEGINTERFERON-ALFA-2B FOR PATIENTS WITH GENOTYPES 2/3 CHRONIC HEPATITIS C UNDER THE PRIVATE PAYER PERSPECTIVE IN BRAZIL
May 1, 2010, 00:00 AM
10.1016/S1098-3015(10)72338-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)72338-X/fulltext
Section Title :
Section Order :
938
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72338-X&doi=10.1016/S1098-3015(10)72338-X